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Abstract
The publication of Disease Control Priorities, 3rd edition (DCP3) is a major milestone in the global health world. 
DCP3 reviews and summarizes high quality health intervention effectiveness and cost-effectiveness evidence 
relevant to low- and middle-income countries and is freely available to users. This Commentary summarizes 
Norheim’s (2018) assessment of DCP3’s role in country health priority-setting and offers reflections on what 
DCP3 can continue to offer countries seeking to improve their purchasing of health.
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The publication of Disease Control Priorities, third edition (DCP3) is a major milestone in the global health world. DCP3 reviews and summarizes 
high quality health intervention effectiveness and cost-
effectiveness evidence relevant to low- and middle-income 
countries and is freely available to users. The primary 
intended users are finance officials who decide how much to 
spend on health in a country and similar decision-makers in 
global health institutions. In that regard the DCP3 follows the 
tradition of the DCP11 and DCP22 of addressing itself directly 
to the holders of health sector purse strings. The 9-volume, 
7-year effort has the capacity to influence people’s health and 
longevity for years to come if the guidance therein is applied 
in many countries.
It is unusual in global health to have a communication 
channel to the finance officials and that is one of the main 
values of DCP to the health community. Typically, priority-
setting in global health is influenced by medical and public 
health voices, accompanied by well-organized and vocal 
advocacy campaigns [see eg, references 10-12 in Norheim 
2018]. The priority-setting process that emerges may not 
result in careful, rational, and pluralistic deliberation using 
evidence.3 The DCP Series, on the other hand, is all about 
evidence. It offers a thorough summation and evaluation of 
the evidence for health policies and interventions available 
from peer-reviewed literature, along with expert judgment 
from hundreds of authors from many countries. At its 
essence, it aims to show decision makers how to spend money 
wisely using the common metric of cost-effectiveness (and its 
variant forms of economic evaluation) interpreted through 
the lens of many authors’ experience. The motivating belief 
of the DCP Series is that this approach – when applied across 
different health needs – will buy more health compared to 
allocating resources by listening only to the voices of interest 
communities. 
In laying out a recipe for national level health priority-
setting, Norheim4 casts some doubt on the DCP formula. 
First, he says that evidence is a starting point, not an end 
in itself. In Norheim’s ideal system – which he describes in 
detail along with a theory of change – evidence “plays a key 
role,” but is only one input in a priority setting model. Priority 
setting works best if economic evidence is subsumed within a 
system that includes multiple steps and actors. Second, by my 
read Norheim would wrest control of the resource allocation 
decision-making from the finance ministry and return it to 
the health bureaucracy and academicians who would mediate 
among political and civil society constituencies. This includes 
ensuring “that the language [of priority-setting] can be 
understood by everyone” involved in all the stages, including 
gathering, interpreting and using the available evidence. 
Third, Norheim points to contextualization as an important 
element missing from the DCP. 
Norheim cogently and convincingly presses his argument 
with examples from literature and experience to lay out a 
theory of change for health priority-setting. But when it 
comes to DCP’s role in that endeavor, his last point is the crux 
of the matter. What can a global project like DCP accomplish 
in laying out the evidence? There is a natural tension between 
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evidence assembled for the purposes of international resource 
allocation decisions and priority-setting needs carefully set 
within national contexts. In this regard Norheim rightly 
points out that improved national priority-setting processes 
do not naturally follow publication of the evidence, however 
thorough, attractive, and available it is. There is no arguing 
with that. DCP provides necessary but not sufficient 
groundwork from which a national process can be developed 
in the form of credible authoritative external evidence but its 
usefulness pre-supposes existing national conditions that are 
favorable to national priority-setting. Norheim names three 
other elements of good national priority setting: (a) clear 
priorities; (b) publicity; and (c) institutionalization. All of 
these need to occur within countries, a territory that DCP has 
relatively little sway over. 
So how can one usefully apply DCP to further those three 
elements? Norheim says, and I agree, that “better national 
priority setting goes beyond what DCP can achieve,” but this 
begs the question of what DCP can and should achieve. 
Here is my list, based on toiling in the priority-setting 
factories of DCP2 and DCP3 for a significant span of my 
career. A DCP enterprise should:
•	 Produce a definitive state-of-the-evidence summary that 
is credible to specialists but not overly technical.
•	 Serve as a reference guide to global health evidence for a 
wide range of users across broad geographies.
•	 Employ a transparent and scientifically balanced process 
to reach conclusions about the evidence.
•	 Indicate honestly the limits of applicability and 
generalizability of the work’s conclusions. 
Beyond those criteria, there are other contributions that a 
DCP can make. Norheim points to a series of steps that – over 
time – will create a fully nationally-owned process for health 
priority-setting. It includes the use of a DCP set of evidence 
as well as assistance from DCP producers in creating local 
institutions that support and maintain local expertise and 
introduction of evidence-based priority-setting within the 
national planning processes. While I agree with Norheim, I 
will go farther to say that DCP could also: 
•	 Help evaluate locally-produced evidence and continue to 
strengthen national capacity, with the aim of generating 
new cadres of experienced analysts that will contribute to 
the next generation of DCP.
•	 More assiduously examine the quality of evidence that 
goes into DCP and explain deviations from the norm that 
inform generalizability. 
•	 Use the synthesis of evidence to propose benchmarks that 
can guide countries in achieving adequate and efficient 
spending on health. 
•	 Create more demand for priority-setting evidence within 
global institutions that national health authorities engage 
with. Here I am thinking about donor organizations 
such as the Global Fund and the Bill & Melinda Gates 
Foundation, as well as policy advocacy groups in global 
health. Both types of organizations heavily influence – 
and sometimes distort – allocational decisions and would 
do well to employ solid evidence in systematic ways in so 
doing. 
•	 Cultivate enduring linkages to the priorities of global 
agencies, professional societies, and agencies – in 
addition to the natural connection to the academy where 
most of the authors are housed. 
•	 Finally, and perhaps most importantly, DCP could work 
closely with countries at different points of their priority-
setting journey, especially to support universal health 
coverage as the agreed vehicle for advancing rational 
healthcare at the national level.
So, how did we – the creators of DCP3 – do on those lists 
of should and coulds? It is not easy to score oneself and 
colleagues, especially with only one year of perspective on a 
7-year process. From my insider vantage point I think we did 
pretty well on the shoulds and even moderately well on the 
coulds. 
•	 DCP3 is a credible and readable summary of evidence for 
a vast array of global health needs. 
•	 It was produced through a transparent and inclusive 
process easily available via the DCP3 website. 
•	 It makes no pretense to be fully generalizable but strives 
to be an honest representation of the evidence and to 
clearly express the limitations. 
•	 It has the potential to be an important reference for 
public health and development professionals. 
The above is a satisfying list, and yet …. DCP3 is not 
currently used by countries that need more priority-setting. 
This is Norheim’s main point and a fact that was brought 
home to me recently in an off-hand remark at lunch by one 
of DCP3’s lead volume editors. This editor, an eminent Indian 
researcher, said no-one talks about DCP3 in his country 
and therefore it “had been a waste of time.” This is a harsh 
judgement, but a telling one. DCP3 has not yet made a 
dent in national priority-setting, even in this editor’s home 
country which has lots of resources relative to many but is 
grossly misdirecting how those resources are used. This 
DCP3 editor had not seen a way to insert DCP3 in priority-
setting in his own country in the manner that Norheim lays 
out. This reflects poorly on the DCP3 leadership, including 
myself. During the process of creating DCP3, we felt that a 
primary outcome was to empower the community of editors 
and authors – hundreds of them – that researched, reflected, 
and wrote the volumes to find ways to use them. They clearly 
believed in DCP3’s usefulness for priority-setting as was 
evident in many planning and draft-sharing meetings and 
channeled into the narrative reviews that they contributed. 
But, generally speaking, they have not yet found the means to 
employ DCP3 in priority-setting in their own countries. One 
possibility – hat tip to an anonymous reviewer – is to better 
exploit the DCP’s historical roots and publishing connection 
to the World Bank to inform the Bank’s interactions with its 
client countries. Evidence from DCP could influence lending 
operations in ways that are less political and more evidence-
based than sometimes is the case. 
The DCP3 Series Editors and Secretariat also believed 
that a major outcome of DCP3 would emerge from this 
community as it put the learning and conclusions of their 
work into practice and shared those ideas with their national 
and international professional networks. And it still may if 
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history is any guide: DCP2 retained its unofficial designation 
as a “bible of global health” for many years after publication 
in 2006, proving its longevity as a global reference guide. 
DCP3 is an up-to-date and expanded replacement of DCP2. 
However, while time may have been a friend to DCP2, it is the 
enemy of DCP3. The 9 volumes took 7 years to produce and 
were published across 3 years. It is difficult for even the most 
committed priority-setters to maintain attention and track 
the shifting outputs and timelines, waiting for their favorite 
topic to finally get its turn. We attempted to reduce the wait 
by publishing drafts of chapters on-line before volumes were 
completed, but this may have also reduced the impact of the 
volumes when they were finally available.
Further, we are not only in a post-DCP2 world. We are 
in a post-DCP3 world. On-line journals publish almost 
in real time, Twitter offers working papers and thoughtful 
discussion of them even faster. The multi-volume format of 
DCP3 was a relic by the time the first volume was published, 
as evidenced by how many hard copies sit on the shelf in the 
DCP3 Secretariat. It would be wrong to take that as a sign that 
DCP3 is not being used in digital format, but frank honesty is 
needed to support and promote its use as a tool (not the tool 
any longer) for priority-setting. 
That returns us to Norheim’s recipe for national priority-
setting processes. As he suggests and knows through 
experience in Ethiopia and elsewhere, establishing a mentality 
for priority-setting in health and implementing it can be a 
long slog. He lays out a timeline and confirms that it can start 
with DCP3. He rightly states that the evidence needs better 
packaging, and it will need translation based on interest and 
capacity, supported by political will. And it needs continued 
funding. Where a global project such as DCP fits into 
Norheim’s actions for better priority setting within a country 
is clear: it should provide evidence to guide countries and 
work with them on methods to translate that evidence and to 
develop the in-house capacity to produce it locally. That is the 
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